Transcranial magnetic stimulation (TMS) and veteran status

Abstract

Get full access to this article

View all access options for this article.

References

Sackeim

Aaronson

Bunker

, et al. The assessment of resistance to antidepressant treatment: rationale for the antidepressant treatment history form: short form (ATHF-SF). J Psychiatr Res 2019; 113: 125–136. https://doi.org/10.1016/j.jpsychires.2019.03.021

Sackeim

Aaronson

Carpenter

, et al. Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation. J Affect Disord 2020; 277: 65–74. https://doi.org/10.1016/j.jad.2020.08.005.3

Wang

Hou

Rui

, et al. Maintenance of noninvasive brain stimulation for preventing relapse in depression: a systematic review and meta-analysis. Alpha Psychiatry 2025; 26(6): 49140. https://doi.org/10.31083/AP49140

Australian Government. Department of Veteran’s Affairs, Fee Schedules for Medical Services . Effective 1 January 2026. See VC51. Web address: https://click.springernature.com/f/a/7DS03VthjjoVmbjD9_H0gg∼∼/AAEGiRA∼/_94XVD4cHEOTH7gjjGZkuI0skn-SN7u_6L_67zWvmCLhPuI9jdRbk6CY2_QuKdXneu14jCG0SGiDrpCyWOGH3fZV8YoOpuO9q-5WKYns_A8mTMp7CJhJbApo1KzSNc8fG1arlbYNb0Xl5Mj0Z5L94jVMiOy2YBZ7p1M8Xc_hSvG8wht39bhUu_vGQAetwx7QnlYAg_zlqsLajKYc4iN9HnFj02SO0be_Z4_OpIBNzfX_gMBuJ0O7blN02O5u5J0H4c6NXwsnYU93nxFQC6Lf9uCITa2DAW_M0cFVZjVdy_7I9ooMRx3qG4OUjJpP6Kp-y

Taylor

Manett

Feyder

, et al. Resource utilization and economic outcomes following repetitive transcranial magnetic stimulation for treatment-resistant depression: a retrospective observational analysis. J Comp Eff Res 2025; 14: e250019. https://doi.org/10.57264/cer-2025-0019

Wang

Meng

Wang

, et al. Vascular endothelial growth factor: a key factor in the onset and treatment of depression. Front Cell Neurosci 2025; 19: 1645437. https://doi.org/10.3389/fncel.2025.1645437